SCHEMBL3198192

SCHEMBL3198192

COC(=O)c1ccc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 10/20 0.82
MAPT P10636 9/20 0.82
MMP9 P14780 5/20 0.82
BACE1 P56817 5/20 0.82
NFKB1 P19838 3/20 0.82
CYP2D6 P10635 2/20 0.82
CYP2C9 P11712 2/20 0.82
TSHR P16473 2/20 0.82
HSD17B10 Q99714 2/20 0.82
ABCB1 P08183 2/20 0.82
AKR1B1 P15121 2/20 0.82
MAOA P21397 2/20 0.82
MAOB P27338 2/20 0.82
ALOX5 P09917 2/20 0.82
STAT3 P40763 2/20 0.82
NFKB2 Q00653 2/20 0.82
RELA Q04206 2/20 0.82
HDAC3 O15379 2/20 0.82
HDAC1 Q13547 2/20 0.82
HDAC2 Q92769 2/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3198180 1.00 APP (0.82) APPMAPTMMP9BACE1NFKB1
SCHEMBL3855986 0.94 NFKB1 (0.84) APPMAPTMMP9BACE1NFKB1
SCHEMBL3855982 0.94 NFKB1 (0.84) APPMAPTMMP9BACE1NFKB1
SCHEMBL4257063 0.90 PTPN1 (0.75) APPMAPTMMP9BACE1NFKB1
SCHEMBL4257060 0.90 PTPN1 (0.75) APPMAPTMMP9BACE1NFKB1
Curcumin SCHEMBL2804734 0.90 APP (1.00) APPMAPTMMP9BACE1NFKB1
Curcumin SCHEMBL250984 0.90 APP (1.00) APPMAPTMMP9BACE1NFKB1
Curcumin SCHEMBL8440 0.90 APP (1.00) APPMAPTMMP9BACE1NFKB1
Curcumin SCHEMBL8336603 0.90 APP (1.00) APPMAPTMMP9BACE1NFKB1
Curcumin SCHEMBL6901740 0.90 APP (1.00) APPMAPTMMP9BACE1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 APP 2/4885MAPT 8/4885MMP9 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.